• Invent Medic’s third-quarter 2026 pretax loss narrowed 32% year over year to SEK 782,000.
• Net sales fell 22% year over year to SEK 1.42 million.
• CEO Gunilla Nilsson said the focus is now on increasing sales, strengthening market presence and accelerating commercial development.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invent Medic Sweden AB published the original content used to generate this news brief via Cision (Ref. ID: 202610220245BITN____UKPR__SV_20261022-BIT-8257-0) on October 22, 2026, and is solely responsible for the information contained therein.